We are live on
!
Find out more
Calamos Advisors Portfolio holdings
AUM
$28.2B
1-Year Est. Return
21.78%
This Fund
S&P 500
This Quarter
Est. Return
+1.86%
1 Year Est. Return
+21.78%
3 Year Est. Return
+69.57%
5 Year Est. Return
+92%
10 Year Est. Return
+282.63%
AUM
$16B
AUM Growth
+$835M
(+5.5%)
Cap. Flow
-$3.09B
Cap. Flow
% of AUM
-19.39%
Top 10 Holdings %
Top 10 Hldgs %
18%
Holding
764
New
113
Increased
285
Reduced
98
Closed
77
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ACT.PRA
ACTAVIS PLC Pfd Conv Ser A (Irl)
ACT.PRA
|
+$231M |
| 2 |
Lockheed Martin
LMT
|
+$82.6M |
| 3 |
Applied Materials
AMAT
|
+$77.5M |
| 4 |
Dollar General
DG
|
+$59.8M |
| 5 |
Comcast
CMCSA
|
+$52.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$70.9M |
| 2 |
Blackstone
BX
|
+$60.7M |
| 3 |
UTX.PRA
UNITED TECHNOLOGIES CORP CORP UNIT (DE)
UTX.PRA
|
+$59.5M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$58.8M |
| 5 |
Apple
AAPL
|
+$56.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.44% |
| 2 | Financials | 10.19% |
| 3 | Healthcare | 10.12% |
| 4 | Consumer Discretionary | 8.73% |
| 5 | Industrials | 7.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
Fossil Group
FOSL
$240M
| $995K | 0.01% |
12,070
+7
| +0.1% | +$644 |
|
402
PUT
TSMC
TSM
$2.03T
| $926K | 0.01% |
+8,822
| New | +$208K |
|
403
Eastman Chemical
EMN
$7.72B
| $925K | 0.01% |
13,362
-287,812
| -96% | -$20.8M |
|
404
Teradata
TDC
$2.82B
| $888K | 0.01% |
20,116
+12
| +0.1% | +$525 |
|
|
NSTG
405
DELISTED
NanoString Technologies, Inc.
NSTG
| $887K | 0.01% |
87,037
| – | – |
|
|
CORI
406
DELISTED
Corium International, Inc.
CORI
| $817K | 0.01% |
129,930
| – | – |
|
407
Monro
MNRO
$525M
| $808K | 0.01% |
12,425
| – | – |
|
408
CALL
Gilead Sciences
GILD
$163B
| $804K | 0.01% |
1,650
-1,040
| -39% | -$106K |
|
409
CALL
Meta Platforms (Facebook)
META
$1.52T
| $792K | 0.01% |
1,390
| – | – |
|
|
DF
410
DELISTED
Dean Foods Company
DF
| $780K | ﹤0.01% |
47,200
+6,325
| +15% | +$109K |
|
|
IPG
411
DELISTED
Interpublic Group of Companies
IPG
| $779K | ﹤0.01% |
35,204
+21
| +0.1% | +$446 |
|
412
TripAdvisor
TRIP
$1.68B
| $778K | ﹤0.01% |
9,353
-10,751
| -53% | -$845K |
|
413
Warner Bros
WBD
$63.6B
| $773K | ﹤0.01% |
25,145
-6,315
| -20% | -$198K |
|
414
ATI
ATI
$25.9B
| $755K | ﹤0.01% |
25,145
+15
| +0.1% | +$466 |
|
415
Globus Medical
GMED
$10.6B
| $755K | ﹤0.01% |
29,900
| – | – |
|
|
TBHC
416
DELISTED
The Brand House Collective
TBHC
| $748K | ﹤0.01% |
31,500
+12,700
| +68% | +$304K |
|
|
DISCK
417
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
| $741K | ﹤0.01% |
25,145
-6,315
| -20% | -$191K |
|
418
CALL
Nu Skin
NUS
$247M
| $739K | ﹤0.01% |
+935
| New | +$47.6K |
|
419
Omnicom Group
OMC
$23.6B
| $738K | ﹤0.01% |
9,470
| – | – |
|
|
PFPT
420
DELISTED
Proofpoint, Inc.
PFPT
| $719K | ﹤0.01% |
12,145
-4,425
| -27% | -$238K |
|
|
ARG
421
DELISTED
Airgas Inc
ARG
| $694K | ﹤0.01% |
6,537
+3
| +0% | +$340 |
|
422
Helmerich & Payne
HP
$3.37B
| $685K | ﹤0.01% |
10,057
+5
| +0% | +$327 |
|
423
Nice
NICE
$5.56B
| $680K | ﹤0.01% |
11,165
+425
| +4% | +$23.4K |
|
424
Red Robin
RRGB
$135M
| $667K | ﹤0.01% |
7,670
-4,150
| -35% | -$336K |
|
425
JetBlue
JBLU
$2.03B
| $664K | ﹤0.01% |
34,500
+18,800
| +120% | +$320K |
|
Similar funds
PCH
N
TWC
FDCDDQ
NA
Calamos Advisors's Q1 2015 Portfolio in Review
As of Q1 2015, Calamos Advisors held 764 positions worth $16B, up 5.5% from $15.1B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Calamos Advisors withdrew a net $3.09B in Q1 2015, closing 77 positions and reducing 98 holdings. Its most notable exit was Harley-Davidson, an estimated $53M position sold in full.
By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Calamos Advisors opened a new position in ACTAVIS PLC Pfd Conv Ser A (Irl) worth $223M.
- Calamos Advisors's largest Q1 2015 buy was ACTAVIS PLC Pfd Conv Ser A (Irl): 220,721 shares worth $223M.
- Calamos Advisors added most to Applied Materials in Q1 2015, an estimated $77.5M increase.
- Calamos Advisors's biggest Q1 2015 reduction was Regeneron Pharmaceuticals, cutting an estimated $70.9M.
- Calamos Advisors fully exited Harley-Davidson in Q1 2015, selling an estimated $53M.
- Calamos Advisors's ten largest holdings make up 18% of its $16B portfolio in Q1 2015.
- Calamos Advisors opened 113 new positions and closed 77 in Q1 2015.
- Calamos Advisors's portfolio value rose 5.5% quarter-over-quarter to $16B.
Based on Calamos Advisors's 13F filing for Q1 2015, filed 13 May 2015.